12hon MSN
Fat cells burn energy to make heat – making them the next frontier of weight loss therapies
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...
Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...
A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...
A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...
Share on Pinterest A new review of evidence found that intermittent fasting is no better than other dietary patterns for weight loss. yunxi xie/Getty Images Researchers report that intermittent ...
The reality star's parents, Todd and Julie, spent two years in federal prison.
Hosted on MSN
Vitamin B12 shots for weight loss: do they work?
This article was reviewed by Lynn Marie Morski, MD, JD. There’s not much research on B12 shots for weight loss. People with obesity tend to have lower vitamin B12 levels, but it’s unclear if B12 shots ...
In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.
Intermittent fasting appears to be no more effective for weight loss than doing nothing at all, according to a review of studies involving people who were overweight or had obesity. The diet has ...
News-Medical.Net on MSN
Drug combination shows greater weight loss while preserving muscle mass
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
Evelyn Parr received funding from the Australian government's Medical Research Future Fund and the Diabetes Australia Research Program for work on time-restricted eating. Intermittent fasting has ...
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results